fiber aids digestion semaglutide tirzepatide Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control 🥦💊 On a GLP-1? You

Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician

For a broader view of which peptides have achieved regulatory approval, see our pillar article: FDA Approved Peptides List 2026

Arbli is the first and only FDA approved ready-to-use oral liquid losartan in the U.S

A well-planned shopping list helps you choose nutrient-dense, diabetes-friendly foods whilst avoiding impulsive purchases that may compromise blood sugar stability